ALEXANDRIA DAVIS-MITCHELL: Open Payments
NPI 1013617505 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 21 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $147 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $163 |
| Indivior Inc. | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $41 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| Almatica Pharma LLC | 1 | $27 |
| Astellas Pharma US Inc | 1 | $25 |
| Amgen Inc. | 1 | $24 |
Products named: Ozempic, Wegovy, SUBLOCADE, REXULTI, MOUNJARO, Rybelsus, ZENPEP, LOREEV XR.
Industry payments across CO — which companies pay providers there.
